Miss Aurelia Elz

Adjunct Associate Research Professor Centre for Cancer Biology

City West Campus ()
tel +61 8 830 21191

email Aurelia.Elz@unisa.edu.au

Research

Research focus

Pharmacology and Pharmaceutical Sciences
Biomedical Engineering
Chemical Engineering
Chemical Sciences
Engineering

Highlights

Cancer immunotherapy

Radiation therapy

Tumour biology

Research

Outputs

Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included.

Open access indicates that an output is open access.

Journal Articles

Year	Output
2024	Ariaee, A, Wardill, HR, Wignall, A, Elz, AS, Wright, L, Prestidge, C & Joyce, P 2024, 'Therapeutic potential of inulin-coated MCT microcapsules in modulating the gut microbiome for effective treatment of diet-induced obesity', Advanced Therapeutics, online, pp. 1-13. Open access 87
2024	Meola, TR, Elz, A, Wignall, A, Paxton, K, Hunter, A, Ariaee, A, Kamath, S, Reuter, SE, Prestidge, CA & Joyce, P 2024, 'Inulin-lipid core-shell microcapsules target the gut microbiota and mimic the pharmaceutical food effect for improved oral antipsychotic delivery', Advanced Functional Materials, vol. 34, no. 40, pp. 1-12. Open access 5 5 85
2024	Meola, TR, Kamath, S, Elz, AS, Prestidge, CA, Wignall, A & Joyce, P 2024, 'Contrasting the pharmacokinetic performance and gut microbiota effects of an amorphous solid dispersion and lipid nanoemulsion for a poorly water-soluble anti-psychotic', European Journal of Pharmaceutics and Biopharmaceutics, vol. 203, pp. 1-10. Open access
2024	Nguyen, TP, Woods, SL, Secombe, KR, Tang, S, Elz, AS, Ayton, S, Finnie, J, Nagpal, A, Pouliot, N & Bowen, JM 2024, 'Ferroptosis - a potential feature underlying neratinib-induced colonic epithelial injury', Cancer Chemotherapy and Pharmacology, vol. 94, no. 4, pp. 493-505. Open access
2024	Taheri, A, Almasri, R, Wignall, A, Schultz, HB, Elz, AS, Ariaee, A, Bremmell, KE, Joyce, P & Prestidge, CA 2024, 'Enhancing the pharmacokinetics of abiraterone acetate through lipid-based formulations: addressing solubility and food effect challenges', Drug Delivery and Translational Research, online.
2023	Subramaniam, S, Elz, A, Wignall, A, Kamath, S, Ariaee, A, Hunter, A, Newblack, T, Wardill, HR, Prestidge, CA & Joyce, P 2023, 'Self-emulsifying drug delivery systems (SEDDS) disrupt the gut microbiota and trigger an intestinal inflammatory response in rats', International Journal of Pharmaceutics, vol. 648, article no. 123614, pp. 1-10. Open access 16 16 5
2022	Elz, AS, Trevaskis, NL, Porter, CJ, Bowen, JM & Prestidge, CA 2022, 'Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport', Journal of Controlled Release, vol. 341, pp. 676-701. 32 28 54
2022	Tam, JS, Crame, EE, Elz, AS, Coller, JK, Wignall, A, Prestidge, CA & Bowen, JM 2022, 'Effects of a novel toll-like receptor 4 antagonist IAXO-102 in a murine model of chemotherapy-induced gastrointestinal toxicity', Cancer Chemotherapy and Pharmacology, vol. 90, no. 3, pp. 267-278. Open access 4 3 1

External engagement & recognition

Collaborations

External engagement & recognition

Collaborations

Organisation	Country
Florey Institute of Neuroscience and Mental Health	AUSTRALIA
La Trobe University	AUSTRALIA
Monash University	AUSTRALIA
Olivia Newton-John Cancer Research Institute	AUSTRALIA
University of Adelaide	AUSTRALIA
University of South Australia	AUSTRALIA
University of Sydney	AUSTRALIA

more less

Miss Aurelia Elz

About me

About me

Centre for Cancer Biology

About me

Professional Associations

Research

Research focus

Highlights

Projects

Outputs

Journal Articles

Current research & highlights

External engagement & recognition

Collaborations

Collaborations

Gallery